spacer
home > epc > autumn 2008 > deliver the goods
PUBLICATIONS
European Pharmaceutical Contractor

Deliver the Goods

Today’s pharmaceutical companies, contract research organisations (CROs) and drug distributors face everincreasing challenges in maintaining the stability and validity of their products in transit. With clinical trials being conducted in new markets and a wide range of countries, the logistics involved in delivering time-critical and temperature controlled investigational medicinal products (IMP) within stability becomes even more challenging. The specialist biopharmaceutical courier companies have risen to this challenge and developed a range of solutions to meet these challenges.

TEMPERATURE CONTROLLED VEHICLE

Temperature controlled vehicles (TCVs) are capable of maintaining a range of temperatures during transit from -25°C up to +20°C through the use of on-board refrigeration and air conditioning units which heat or chill the air in the insulated cargo compartment of the vehicle to the temperature set. Clinical trial medicines that need to be kept between +2 and +8°C can be collected from the shipper, loaded into a pre-conditioned TCV and then driven directly to the consignee anywhere within the UK, Western Europe, Eastern Europe and as far afield as Russia.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Don Riach has extensive freight forwarding, import, export, clinical trial distribution, cold chain and courier experience, having worked previously for Scottish Express Intl, Syntex Research, Roche and Quintiles. Don holds an IATA FIATA Diploma with distinction, Institute of Export and Dangerous Goods by Air qualifications and graduated from Napier University, Edinburgh, gaining a BA in Business Studies in 2005. Don joined Marken, a specialist time critical courier company, from Quintiles in 2000 and is currently the Regional Manager for Scotland based in Edinburgh.
spacer
Don Riach
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Destiny Pharma appoints MedPharm to develop new XF-platform drug formulations

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Company’s novel XF-platform compounds. These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR). MedPharm is a world leading contract provider of topical and transdermal product design and formulation development services using sophisticated in vitro models to de-risk development programmes.
More info >>

White Papers

Generating Scientific Insights by Deep Collaboration - Bridging the Big Data Divide Between Clinical and Research

BioFortis

Translational research, biomarker discovery, clinical studies and even biobanking have become increasingly data intensive.  However, generating scientific insights from such disparate “big” data sources across multiple domains is a challenge for both researchers and the informaticians that support them. Download our Deep Collaboration Whitepaper and and learn how to bridge the clinical and research divide to better explore your biomarker based trials.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement